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Abstract: A range of substituted dihydroisoquinolinium salts has been tested in the catalytic 
asymmetric epoxidation of simple alkenes using our newly developed non-aqueous conditions 
employing tetraphenylphosphonium mono-peroxysulfate (TPPP) as oxidant, giving ees of up to 97%.  
 
In 1976 it was established that oxaziridinium salts are extremely reactive reagents for oxygen transfer to 
nucleophilic substrates.2 Since then, there has been significant interest in developing effective iminium salt 
catalysts for epoxidation of olefins.3 The primary oxidant used is oxone, and the reactions are usually 
performed at 0 ºC in the presence of a base. In addition to an organic solvent, usually acetonitrile, water is 
an essential cosolvent, required in order to provide sufficient oxone solubility.  
 
We have previously described our approach to new types of cyclic chiral iminium salts, functionalized with 
chiral units at the nitrogen atom.4 These enantiomerically pure iminium salts have been successfully 
employed in the catalytic asymmetric epoxidation of unfunctionalized alkenes, the dioxane-derived catalysts 
1-5 giving ees of up to ca 60%,5 catalyst 6 giving ees of up to 97%,6 and catalyst 7 ees of up to 95%.7  
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The standard conditions employed by ourselves and others in epoxidation reactions catalysed by iminium 
salts involve the use of oxone as stoicheiometric oxidant, a base (2 mol eq of Na2CO3 per eq of oxone) and 
water / acetonitrile as solvent mixture.  
 
The principal limitation of this system is the restricted range of temperatures at which the epoxidation can be 
performed (ca –5 °C to ambient). The upper temperature limit results from the relatively fast decomposition 
of oxone in basic media at room temperature. The lower limit is determined by the requirement for an 
aqueous solution (the normal ratio of solvents is (CH3CN:H2O; 1:1); aqueous acetonitrile freezes at –8 °C. 
An additional drawback arising from the dependency on oxone is the large quantity of inorganic salt 
byproducts produced in the reaction.  
 
We have recently described new reaction conditions for iminium salt-catalysed epoxidation, which eliminate 
the use of both water and base.8 This was achieved through the identification of an effective oxidant, 
tetraphenylphosphonium monoperoxysulfate (TPPP), that is soluble in organic solvents. When oxone is 
treated with tetraphenylphosphonium chloride, TPPP is produced as a colourless solid (Equation 1). TPPP 
has previously been used for the oxidation of manganese(III) porphyrins.9  
 
Ph4P+ Cl– + Oxone (KHSO4:2KHSO5:K2SO4) → Ph4P+(HSO5)–  
Equation 1  
 
We were pleased to find that the use of TPPP in place of oxone induces efficient epoxidation in organic 
solvents in the absence of water, and furthermore that the presence of base is now not required; indeed, 
addition of base actually suppresses the epoxidation process. Use of this oxidant also enables greater scope 
for reaction monitoring and analysis, as water is no longer required. Reactions can be carried out at low 
temperature, and, when carried out in deuteriated solvent, monitored by NMR spectroscopy. We describe 
herein the catalytic asymmetric epoxidation of several unfunctionalized alkenes using catalysts 2-6 under the 
new anhydrous conditions, employing (TPPP) as stoichieometric oxidant. The catalysts were first tested in 
the asymmetric epoxidation of 1-phenycyclohexene at varying temperatures using TPPP in dichloromethane 
(Table 1).  
 
As the temperature is reduced there is an increase in enantiomeric excess at the expense of rate of 
conversion to epoxide. It is interesting that, while catalyst 1 gives the (–)-(1S,2S) epoxide, when the catalyst 
contains a strongly electron-withdrawing nitro or sulfone substituent (catalysts 2 and 6), a change in the 
configuration of the enantiomer of epoxide formed preferentially, to the (+)-(1R,2R) isomer, is observed in 
every case.  
 
The thiomethyl catalyst 3 also gives the (+)-(1R,2R) enantiomer of 1-phenycyclohexene preferentially, but 
only between temperatures of 0 ºC and –50 ºC (Table 1, entries 3, 8, 12); at –78 ºC the (–)-(1S,2S) 
enantiomer is preferentially formed (Table 1, entry 18). We reason that this is due to rapid oxidation of the 
sulfide to the sulfone at temperatures above –78 ºC, generating catalyst 6 in situ. Catalyst 4, which contains 
an electron-donating methoxy substituent, and has the opposite absolute stereochemistry to catalysts 1, 2, 3 
and 6, produces the (+)-(1R,2R) epoxide enantiomer preferentially, regardless of temperature. Catalyst 4 
thus exhibits the same facial selectivity as unsubstituted catalyst 1 (and catalyst 3 at low temperatures).  
 
In the case of catalyst 3, to prove that the active catalyst at temperatures above –78 ºC was indeed the 
corresponding sulfone 6, a standard epoxidation reaction was performed in deuteriated dichloromethane 
solution, and the reaction mixture subjected to 1H NMR spectroscopic analysis. The chemical shift for the 
methyl group attached to sulfur had shifted from δ 2.42 to 3.03, confirming that the sulfide had been 
oxidized to the sulfone, by comparison with authentic catalyst 6. The sulfoxide intermediate was not 
observed.  
 
Table 1: Catalytic asymmetric epoxidation of 1-phenycyclohexene using TPPP in CH2Cl2a  
Entry Temp/ºC Catalystb Conversion/%c ee/%d Configuratione 
1 0 1 100 16 (–)-(1S,2S) 
2  2 100 25 (+)-(1R,2R) 
3  3 72 16 (+)-(1R,2R) 
4  4 f — — —  
5  6 100 33 (+)-(1R,2R) 
6 –30 1 — — — 
7  2 100 28 (+)-(1R,2R) 
8  3 92 33 (+)-(1R,2R) 
9  4 f 76 25 (+)-(1R,2R) 
10  6 100 36 (+)-(1R,2R) 
11 –45 1 70 37g (–)-(1S,2S) 
12  2 54 30 (+)-(1R,2R) 
13  3 67 33 (+)-(1R,2R) 
14  4 f — — — 
15  6 96 42 (+)-(1R,2R) 
16 –78 1 15 23h (–)-(1S,2S) 
17  2 0 — — 
18  3 15 50h (–)-(1S,2S) 
19  4 f 13 29h (+)-(1R,2R) 
20  6 – — —  
 
a
 Epoxidation conditions: iminium salt (10 mol%), TPPP (2 eq), CH2Cl2, 4 h. b 
Catalyst configuration (4S,5S) unless otherwise stated. c Conversions were evaluated 
from the 1H NMR spectra by integration of alkene and epoxide signals. d 
Enantiomeric excesses were determined by 1H NMR spectroscopy in the presence of 
(+)-Eu(hfc)3 (0.1 mol eq). e The absolute configurations of the major enantiomers 
were determined by comparison of optical rotation with literature values. f Catalyst 
configuration (4R,5R). g Reaction carried out at –40 ºC. h Reaction time 8 h.  
 
In order to determine the effects of solvent on the reaction, several other solvents were screened using our 
three most enantioselective catalysts 1, 4 and 6 (Table 2). TPPP was found to be insoluble in carbon 
tetrachloride, ethyl acetate and dimethoxyethane. In dimethylformamide, the TPPP dissolved but no reaction 
occurred. TPPP is also soluble in dichloroethane, however, and epoxidation reactions of 1-
phenylcyclohexene performed in this solvent gave almost identical results to those obtained with 
dichloromethane for catalysts 6 and 4. Curiously, catalyst 1 was far less reactive in this medium and gave a 
reduced ee (24% compared to 37%). When the reactions were repeated in chloroform, we observed a 
dramatic decrease in ee for catalyst 4, while catalyst 1 gave similar results to those obtained in 
dichloromethane (33% ee). Catalyst 6 in chloroform, however, gave the best ee for 1-phenylcyclohexene 
(48% ee) that we have observed with this series of iminium salt catalysts. Interestingly, in acetonitrile at –30 
ºC we observed a similar degree of enantioselectivity to that seen in the reaction carried out in chloroform 
(48% ee, (+)-(1R,2R) enantiomer), but producing the opposite (–)-(1S,2S)-enantiomer of phenycyclohexene 
oxide in 45% ee. The origins of these solvent effects upon enantioselectivity remain unclear.  
 
Table 2: Asymmetric epoxidation of 1-phenylcyclohexene using various solvents a  
Solvent Catalystb Time/h Conversion/%c ee/%d Configuratione 
CH3CN 1 1.0 42 43 f (–)-(1S,2S) 
 4 g 0.2 30 44 (+)-(1R,2R) 
 6 2.5 89 45 (–)-(1S,2S) 
CH2Cl2 1 4 70 37 f (–)-(1S,2S) 
 4 g 4 76 25 (+)-(1R,2R) 
 6 4 100 36 (+)-(1R,2R) 
C2H4Cl2 1 24 29 24 (–)-(1S,2S) 
 4 g 24 87 17 (+)-(1R,2R) 
 6  4 97 32 (+)-(1R,2R) 
CHCl3 1 24 52 33 (–)-(1S,2S) 
 4 g 24 73 11 (+)-(1R,2R) 
 6  12 100 48 (+)-(1R,2R) 
 
a
 Epoxidation conditions: iminium salt (10 mol %), TPPP (2 eq), solvent, –30 °C. x 
Catalyst configuration (4S,5S). b Catalyst configuration (4S,5S) unless otherwise 
stated. c Conversions were evaluated from the 1H NMR spectra by integration of 
alkene and epoxide signals. d Enantiomeric excesses were determined by 1H NMR 
spectroscopy in the presence of (+)-Eu(hfc)3 (0.1 mol eq). e The absolute 
configurations of the major enantiomers were determined by comparison of optical 
rotation with literature values. f Reaction carried out at – 40 °C. g Catalyst 
configuration (4R,5R).  
 
Using our most enantioselective catalyst 6, we next carried out asymmetric epoxidations of several other 
unfunctionalized alkenes in acetonitrile and in choloroform solution at a standard temperature of –40 ºC, 
using 10 mol% catalyst (Table 3). Remarkably, changing the reaction solvent was found to switch the major 
enantiomer of epoxide generated from all trans- and tri-substituted alkenes tested. Further, trans-stilbene, 
usually a poor substrate with our catalysts (less than 5% ee was observed under our original aqueous 
conditions using the same catalyst and oxone), afforded the (+)-(R,R) enantiomer of trans-stilbene oxide in 
67% ee when the reaction was carried out in chloroform solution, but the (–)-(S,S) isomer, in 30% ee, when 
performed in acetonitrile. With the exception of α-methylstilbene, it is clear from table 3 that chloroform is 
the solvent of choice for catalyst 6, and the enantiomeric excesses are far better than those observed when 
employing TPPP in acetonitrile as well as in the original aqueous conditions using oxone.  
 
Table 3: Catalytic asymmetric epoxidation of various alkenes using TPPP and catalyst 6 a  
Solvent Oxone/CH3CN/H2O CH3CN CHCl3  
Alkene Yield/ 
%b 
ee/ 
%c 
Configd Yield/ 
%b 
ee/ 
%c 
Configd Yield/ 
%b 
ee/ 
%c 
Configd 
Ph
 
100 e 39 (–)-(1S,2S) 73 45 (–)-(1S,2S) 77 48 (+)-(1R,2R) 
Ph
Ph
 
100 e <5 (–)-(S,S) 13e 30 (–)-(S,S) 31 67 (+)-(R,R) 
Ph
Ph
CH3 
100 e 32 (–)-(1S,2R) 42 48 (–)-(1S,2R) 35 2 (+)-(1R,2S) 
Ph
Ph
Ph 
100 e 50 (+)-(S) 25 27 (+)-(S) 11e 63 (–)-(R) 
Ph
 
100 e 47 (–)-(1S,2R) 56 38 (–)-(1S,2R) 98 59 (+)-(1R,2S) 
 
- - - 71 53 (+)-(1S,2R) 85 70 (+)-(1S,2R) 
 
- - - - - - 83 61 (+)-(1S,2R) 
 
61 45 (–)-(1S,2R) 80 56 (–)-(1S,2R) 89 82 (–)-(1S,2R) 
O
O2N
 
- - - - - - 52 88 (–)-(1S,2S) 
O
Cl
 
- - - - - - 76 93 (–)-(1S,2S) 
O
NC
 
- - - 63 80 (–)-(1S,2S) 59 97 (–)-(1S,2S) 
a
 Epoxidation conditions: iminium salt  6 (10 mol%), TPPP (2 eq), –40 °C, 24 h.  b 
Isolated yields unless otherwise stated. c Enantiomeric excesses were determined by 
1H NMR spectroscopy in the presence of (+)-Eu(hfc)3 (0.1 mol eq) or by chiral HPLC 
using a Chiracel OD column. d The absolute configurations of the major enantiomers 
were determined by comparison of optical rotation with literature values. e 
Conversions, evaluated from the 1H NMR spectra by integration of alkene and 
epoxide signals.  
 
Good enantiomeric excesses were also observed for cis-α-methyl styrene (70% ee) and dihydronaphthalene 
(82% ee). The level of enantioselectivity observed here is remarkable given that the corresponding reaction 
carried out under our standard aqueous conditions with oxone afforded dihydronaphthalene oxide in only 
45% ee. The enantiomeric excess for the epoxidation of indene is somewhat lower (61% ee), but is still 
much higher than other reported ees for this epoxidation when mediated by oxaziridinium salts.5 
Epoxidation of the non-aryl cis-hept-2-ene produced epoxide with quantitative conversion but with low ee. 
Electron-deficient alkenes are also poor substrates.  
 
Finally, we turned our attention to the epoxidation of benzopyran substrates. We were delighted to observe 
excellent enantioselectivities in the epoxidations of 6-nitro-, 6-chloro-, and 6-cyano- 2,2-
dimethylbenzopyrans, with ees up to an unprecedented 97%.6 It is interesting to note here that, in these 
cases, whichever solvent was employed, the same enantiomer of epoxide was observed.  
 
Conclusions  
A range of iminium salt asymmetric epoxidation catalysts has been tested under non-aqueous conditions at 
various temperatures in a number of solvents; from these we have identified catalyst 6 as one of the most 
enantioselective. The reaction solvent has a profound effect on the epoxidation of trans- and tri-substituted 
alkenes, and in many cases we are able to produce either enantiomer as the major product by choice of 
acetonitrile or chloroform as solvent. In terms of enantiomeric excesses, the optimum reaction temperature 
appears to be –40 ºC and chloroform the solvent of choice. These conditions have provided enantiomeric 
excesses of up to 97%, in the epoxidation of 6-cyano-2,2-dimethylbenzopyran.  
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Experimental  
General Details. All infrared spectra were obtained using a Perkin-Elmer Paragon 1000 FT-IR 
spectrophotometer; thin film spectra were acquired using sodium chloride plates. All 1H and 13C NMR 
spectra were measured at 250.13 and 62.86 MHz with a Bruker AC 250 MHz spectrometer or at 400.13 and 
100.62 MHz with a Bruker DPX 400 MHz spectrometer, in deuteriochloroform solution unless otherwise 
stated, using TMS (tetramethylsilane) as the internal reference. Mass spectra were recorded using a Jeol-
SX102 instrument utilizing electron-impact (EI), fast atom bombardment (FAB), and by the EPSRC 
national mass spectrometry service at the University of Wales, Swansea, utilising electrospray (ES.).  
Analysis by GCMS utilized a Fisons GC 8000 series (AS 800), using a 15 m x 0.25 mm DB-5 column and 
an electron-impact low resolution mass spectrometer. Melting points were recorded using an Electrothermal-
IA 9100 melting point instrument and are uncorrected. Optical rotation values were measured with an 
Optical Activity-polAAar 2001 instrument, operating at λ=589 nm, corresponding to the sodium D line, at 
the temperatures indicated. Microanalyses were performed on a Perkin Elmer Elemental Analyser 2400 
CHN. All chromatographic manipulations used silica gel as the adsorbent.  Reactions were monitored using 
thin layer chromatography (TLC) on aluminium-backed plates coated with Merck Kieselgel 60 F254 silica 
gel. TLC plates were visualised by UV radiation at a wavelength of 254 nm, or stained by exposure to an 
ethanolic solution of phosphomolybdic acid (acidified with concentrated sulphuric acid), followed by 
charring where appropriate. Reactions requiring anhydrous conditions were carried out using glassware 
dried overnight at 150 ºC, under a nitrogen atmosphere unless otherwise stated. Reaction solvents were used 
as obtained commercially unless otherwise stated. Light petroleum (b.p. 40-60 ºC) was distilled from 
calcium chloride prior to use. Ethyl acetate was distilled over calcium sulphate or chloride. Dichloromethane 
was distilled over calcium hydride. Tetrahydrofuran was distilled under a nitrogen atmosphere from the 
sodium/benzophenone ketyl radical or from lithium aluminium hydride. Enantiomeric excesses were 
determined either by proton nuclear magnetic resonance spectroscopy in the presence of europium (III) 
tris[3-(hepta-fluropropylhydroxymethylene)-(+)-camphorate] as the chiral shift reagent, or by chiral HPLC 
using a Chiracel OD column on a TSP Thermo-Separating-Products Spectra Series P200 instrument, with a 
TSP Spectra Series UV100 ultra-violet absorption detector set at 254 nm and a Chromojet integrator.  
 
General procedure for the preparation of dihydroisoquinolinium salts from 2-(2-bromoethyl) 
benzaldehyde and primary amines.  
2-(2-Bromoethyl)benzaldehyde (1.60 equiv., 1.10 if freshly distilled) was cooled using an ice bath, and a 
solution of the amine in ethanol (10 ml per g of amine) was added dropwise. After the addition was 
complete, the ice bath was removed and the reaction mixture stoppered to retain HBr, and stirred overnight. 
A solution of sodium tetraphenylborate or other anion-exchanging salt (1.10 equiv.) in the minimum amount 
of acetonitrile was added in one portion to the reaction mixture. After stirring for 5 min, the organic solvents 
were removed under reduced pressure. Ethanol was added to the residue, followed by water. The resulting 
precipitate was collected by filtration and washed with additional ethanol followed by diethyl ether. If no 
solid materialized after the addition of the water, the mixture was allowed to settle and the ethanol/water 
phase was decanted. The gummy residue was triturated in hot ethanol or methanol, inducing precipitation of 
the organic salt immediately or upon slow cooling of the hot alcoholic solution. Small quantities of 
acetonitrile may be added during this process to aid solubility.  
 
(+)-N-((4S,5S)-2,2-Dimethyl-4-phenyl-1,3-dioxan-5-yl)-3,4-dihydroisoquinolinium tetraphenylborate 
(1).5 
Prepared according to the general procedure from (4S,5S)-5-amino-2,2-dimethyl-4-phenyl-1,3-dioxane (3.00 
g, 14.4 mmol), and purified by recrystallization from acetone/diethyl ether to give 1 as a yellow solid (6.93 
g, 75%), m.p. 169-170 ºC; [α]20D +38.6º (c 2.70, CH3CN); νmax/cm-1 (nujol) 1637, 1603, 1571, 1480, 1266, 
1202, 1166, 1108, 1073; δH (250 MHz; CD3CN), 1.65 (3 H, s), 1.94 (3 H, s), 2.39-2.48 (1 H, m), 2.70-2.82 
(1 H, m), 3.25-3.40 (1 H, m), 3.81-3.97 (1 H, m), 4.00-4.10 (1 H, m), 4.30 (1 H, d, J 13.7 Hz), 4.58 (1 H, dd, 
J 13.7, 3.1 Hz), 5.70 (1 H, d, J 2.8 Hz), 6.81 (4 H, t, J 7.2 Hz), 7.35-7.40 (6 H, m), 7.46 (1 H, t, J 7.3 Hz), 
7.65-7.74 (2 H, m), 8.92 (1 H, s); δC (62.50 MHz; CD3CN) 17.9, 24.1, 28.7, 51.6, 61.4, 65.5, 70.7, 104.9, 
121.9, 124.3, 125.4, 125.7, 128.1, 128.5, 128.6, 128.0, 134.4, 135.8, 137.0, 137.7, 138.7, 163.5, 167.5; m/z 
322.1809; C21H24NO2 (cation) requires 322.1807.  
 
(+)-N-((4S,5S)-2,2-Dimethyl-4-(4-nitrophenyl)-1,3-dioxan-5-yl)-3,4-dihydroisoquinolinium 
tetraphenylborate (2).5 
Prepared according to the general procedure from (+)-(4S,5S)-5-amino-2,2-dimethyl-4-(4-nitrophenyl)-1,3-
dioxane (0.19 g, 0.8 mmol), and purified by recrystallization from CH2Cl2/hexane to give 2 as yellow plates 
(0.36 g, 74%); m.p. 176-178 ºC (dec.); [α]20D +107.7º (c=1.30, acetone); Found C, 77.73; H, 6.23; N, 4.00; 
C45H43BN2O4⋅0.5H2O requires: C, 77.66; H, 6.38; N, 4.03.; νmax(film) /cm-1 1635, 1604, 1571, 1524, 1478, 
1384, 1202, 1163, 1107, 1032; δH (400 MHz; acetone-d6), 1.72 (3H, s, CH3, C7), 1.76 (3H, s), 2.70-2.80 (1 
H, m), 2.88-2.96 (1 H, m), 3.65-3.74 (1 H, m), 4.19-4.23 (1 H, m), 4.54 (1 H, d, J 13.6 Hz), 4.61-4.70 (1 H, 
m), 4.82 (1 H, dd, J 13.6, 2.8 Hz), 6.11 (1 H, d, J 2.4 Hz), 6.80 (4 H, t, J 6.8 Hz), 6.94 (8 H, t, J 7.2 Hz), 
7.36 (8 H, m), 7.51 (1 H, t, J 7.6 Hz), 7.59-7.88 (3 H, m), 7.85 (2 H, d, J 8.4 Hz), 7.95 (2 H, d, J 8.8 Hz), 
9.28 (1 H, s); δC (100 MHz; acetone-d6), 19.2, 25.9, 30.0, 52.8, 63.4, 66.4, 71.9, 102.2, 122.7, 125.3, 125.8, 
126.4, 128.3, 129.7, 129.8, 135.9, 137.4, 138.4, 140.1, 145.0, 149.0, 165.0, 169.5; m/z 367.1658; C21H23N2O4 
(cation) requires 367.1658.  
 
(+)-N-((4S,5S)-2,2-Dimethyl-4-(4-(methylthio)phenyl)-1,3-dioxan-5-yl)-3,4-dihydroisoquinolinium 
tetraphenylborate (3).5 
Prepared according to the general procedure from (4S,5S)-5-amino-2,2-dimethyl-4-(4-(methylthio)phenyl)-
1,3-dioxane (0.50 g, 2.0 mmol), and purified by recrystallization from CH2Cl2/hexane to give 3 as yellow 
plates (1.00 g, 73%); m.p. 146-148 ºC (dec.); [α]20D +115.9º (c 1.41, acetone); Found: C, 79.05; H, 6.59; N, 
1.93. C46H46BNO2S⋅0.5H2O requires C, 79.27; H, 6.66; N, 2.01.; νmax(film) /cm-1 3053, 2996, 2360, 2341, 
1634, 1603, 1571, 1478, 1265, 1201, 1162, 1108, 1075; δH (250 MHz; acetone-d6) 1.66 (3H, s), 1.72 (3H, s), 
2.42 (3H, s), 2.66-2.84 (1 H, m), 2.90-3.03 (1 H, m), 3.62-3.74 (1 H, m), 4.13-4.26 (1 H, m), 4.50-4.55 (2 H, 
m), 4.78 (1 H, dd, J 13.8, 3.1 Hz), 5.91 (1 H, d, J 2.6 Hz), 6.78 (4 H, t, J 7.2 Hz), 6.92 (8 H, t, J 7.40 Hz), 
7.34 (8 H, m), 7.40-7.56 (6 H, m), 7.76-7.87 (2 H, m), 9.30 (1 H, s); δC (100 MHz; acetone-d6) 15.4, 18.8, 
25.4, 30.0, 52.3, 62.7, 66.5, 71.5, 101.4, 122.3, 125.3, 126.1, 126.9, 127.4, 129.2, 129.3, 133.9, 135.2, 137.0, 
137.8, 139.5, 140.5, 165.0, 168.5; m/z 368.1682; C22H26NO2S (cation) requires 368.1684.  
 
(–)-N-((4R,5R)-2,2-Dimethyl-4-[4-methoxyphenyl)-1,3-dioxan-5-yl)-3,4-dihydroisoquinolinium 
tetraphenylborate (4).5  
Prepared according to the general procedure from (–)-(4R,5R)-5-amino-2,2-dimethyl-4-(4-methoxyphenyl)-
1,3-dioxane (0.40 g, 1.7 mmol), and purified by recrystallization from CH2Cl2/hexane to give 4 as yellow 
plates (0.83 g, 74%); m.p. 171-173 ºC (dec.); [α]20D –108.6º (c 1.40, acetone); νmax(film) /cm-1 1639, 1604, 
1573, 1514, 1382, 1254, 1202, 1107, 1031; Found C, 77.70; H, 6.50; N, 1.88. C46H46BNO3⋅0.5Et2O requires 
C, 77.92; H, 6.54; N, 1.98.; δH (400 MHz; CDCl3) 1.51 (3H, s), 1.52 (3H, s), 2.20-2.25 (1 H, m), 2.31-2.35 
(1 H, m), 2.85-2.90 (1 H, m), 3.00-3.10 (1 H, m), 2.96-3.07 (1 H, m), 3.56 (1 H, d, J 14.4 Hz), 3.72 (3 H, s), 
3.90 (1 H, dd, J 14.0, 2.8 Hz), 5.11 (1 H, d, J 2.4 Hz), 6.79 (2 H, d, J 2.0 Hz), 6.87 (4 H, t, J 7.2 Hz), 7.02 (8 
H, t, J 7.6 Hz), 7.23-7.24 (2 H, m) 7.24-7.31 (1 H, m), 7.41-7.57 (8 H, m), 7.60-7.69 (1 H, m), 8.25 (1 H, s); 
δC (100 MHz; CDCl3) 18.4, 24.6, 29.4, 50.5, 55.4, 61.9, 64.9, 70.5, 100.4, 114.4, 122.2, 123.7, 125.9, 127.3, 
127.9, 128.7, 129.5, 134.0, 134.7, 136.2, 138.8, 159.8, 163.8, 169.5; m/z 352.1915; C22H26NO3 (cation) 
requires 352.1913.  
 
(+)-N-((4S,5S)-2,2-Dimethyl-4-(4-(methylsulfonyl)phenyl)-1,3-dioxan-5-yl)-3,4-dihydroisoquinolinium 
tetraphenylborate (6).6  
Prepared according to the general procedure from (4S,5S)-5-amino-2,2-dimethyl-4-[4-
(methylsulfonyl)phenyl]-1,3-dioxane (0.75 g, 2.96 mmol), and purified by recrystallization from 
CH2Cl2/hexane to give 6 as yellow plates (1.55 g, 73%); m.p. 199-201 ºC (dec.); [α]20D +126.7º (c 1.20, 
acetone); Found: C, 75.62; H, 6.32; N, 1.84. C46H46BNO4S⋅0.5H2O requires C, 75.79; H, 6.50; N, 1.92.; 
νmax(film) /cm-1 1636, 1603, 1572, 1478, 1383, 1314, 1266, 1202, 1150, 1076, 1032, 956; δH (400 MHz; 
acetone-d6), 1.69 (3H, s), 1.72 (3H, s), 2.60-2.69 (1 H, m), 2.85-2.96 (1 H, m), 3.00 (3H, s), 3.65-3.72 (1 H, 
m), 4.12-4.20 (1 H, m), 4.49 (1 H, d, J 13.6 Hz), 4.50-4.64 (1 H, m), 4.77 (1 H, dd, J 13.6, 2.8 Hz), 6.05 (1 
H, d, J 2.8 Hz), 6.80 (4 H, t, J 7.2 Hz), 6.92 (8 H, t, J 7.2 Hz), 7.31-7.44 (8 H, m), 7.49 (1 H, t, J 7.6 Hz), 
7.73-7.83 (3 H, m), 7.82 (2 H, d, J 8.2 Hz), 7.95 (2 H, d, J 8.2 Hz), 9.28 (1 H, s); δC (100 MHz; acetone-d6), 
18.8, 25.4, 29.5, 44.3, 52.3 62.9, 66.1, 71.5, 101.7, 122.3, 125.3, 126.1, 127.6, 128.8, 129.3, 129.4, 135.4, 
137.0, 137.0, 137.9, 142.4, 143.2, 165.0, 168.9; m/z 400.1586; C22H26NO4S (cation) requires 400.1583.  
 
Tetraphenylphosphonium monoperoxysulfate.  
OxoneTM triple salt (2 KHSO5:KHSO4:K2SO4) (15.0 g, 48.8 mmol with respect to KHSO5) was dissolved in 
deionized water (300 ml), and the solution stirred at 10–15 ºC (water bath). A solution of 
tetraphenylphosphonium chloride (15.0 g, 40.0 mmol) in distilled dichloromethane (300 ml) was added over 
5 min, and the mixture stirred for an additional 30 min. The organic layer was separated, and the solvent 
removed under reduced pressure at room temperature. The colourless residue, the crude salt, was transferred 
to a fritted glass funnel and washed with distilled water (2 x 75 ml). The solid was dissolved in 
dichloromethane (180 ml), and the solution dried (MgSO4). Hexane was added until cloudiness developed, 
and the flask was placed in the freezer (–20 ºC) overnight, producing a colourless precipitate of the salt 
about 85% pure in peroxide (15.4 g, 70%). δH (250 MHz; CDCl3) 7.62-7.65 (8 H, m), 7.76-7.81 (8 H, m), 
7.88-7.92 (4 H, m), 8.92 (1 H, s).  
 
General procedure for catalytic asymmetric epoxidation of simple alkenes mediated by iminium salts 
using tetraphenylphosphonium monoperoxysulfate.  
Tetraphenylphosphonium monoperoxysulfate (2 equiv. with respect to the alkene) was dissolved in the 
desired solvent (2 ml per 0.1 g oxidant) and the solution cooled to the required temperature. To this was 
added the iminium salt as a solution in the solvent (0.5 ml per 0.1 g oxidant). This iminium salt solution was 
cooled to the same temperature as the solution containing the oxidant and added to it dropwise over 15-20 
min; the temperature of the reaction vessel was monitored to minimize increase in temperature during the 
addition. A solution of the alkene in the reaction solvent (0.5 ml per 0.1 g oxidant) was added dropwise. The 
mixture was stirred at the reaction temperature until the alkene was completely consumed according to tlc. 
Diethyl ether (pre-cooled to the reaction temperature) (20 ml per 0.1 g oxidant) was added to induce 
precipitation of the remaining oxidant, and the mixture filtered through Celite. The solvents were removed, 
diethyl ether (40 ml) was added to the residue, and the solution passed through a short pad of silica gel to 
remove catalyst residues. The solvents were removed to give the epoxide. If the reaction does not reach 
completion the epoxide can be separated from the alkene by column chromatography, eluting with ethyl 
acetate/light petroleum 1:99.  
 
General procedure for the catalytic asymmetric epoxidation of alkenes mediated by iminium salts 
using Oxone.  
Oxone (2 equiv. with respect to alkene) was added with stirring to an ice-cooled solution of sodium 
carbonate (4 equiv.) in water (12 ml per 1.50 g of sodium carbonate), and the resulting foaming solution 
stirred for 5-10 minutes, until most of the initial effervescence subsided. A solution of the iminium salt (10 
mol% with respect to alkene) in acetonitrile (6 ml per 1.50 g of sodium carbonate used) was added, followed 
by a solution of the alkene in acetonitrile  (6 ml per 1.50 g of sodium carbonate used). The suspension was 
stirred with ice bath cooling until the substrate was completely consumed according to tlc. The reaction 
mixture was diluted with ice-cooled diethyl ether (20 ml per 100 mg substrate) and the same volume of 
water added immediately. The aqueous phase was washed four times with diethyl ether, and the combined 
organic solutions washed with brine and dried (MgSO4). Filtration and removal of the solvents gave a 
yellow or light brown residue, which was purified by column chromatography, typically using ethyl 
acetate/light petroleum (1:99), to provide the pure epoxide.  
 
General procedure for the formation of racemic epoxides.  
The alkene was dissolved in CH2Cl2 (10 ml/g) and the solution cooled using an ice bath. A solution of m-
CPBA (2 eq.) in CH2Cl2 (10 ml/g, pre-dried over MgSO4) was added. The reaction was allowed to reach 
ambient temperature and stirred until complete consumption of the substrate was observed by tlc. Saturated 
aqueous NaHCO3 (10 ml/g) was added and the layers separated. The organic layer was washed with 
saturated aqueous NaOH (1.0 M, 10 ml/g) and dried (MgSO4). The solvents were removed under reduced 
pressure, and the residue purified by column chromatography, typically eluting with ethyl acetate/light 
petroleum (1:99), to give the pure epoxide.  
 
trans-α-Methylstilbene oxide.10 Colourless oil; νmax(neat)/cm-1 3061, 1602, 1495, 1449, 1381, 1279, 1157, 
1118, 1065, 1027, 980; δH(400 MHz; CDCl3) 1.46 (3 H, s), 3.96 (1 H, s), 7.30-7.46 (10 H, m); δC(100 MHz; 
CDCl3) 17.1, 63.5, 67.5, 125.6, 126.9, 127.7, 127.9, 128.6, 129.2, 136.4, 142.8.  
 
Triphenylethylene oxide.11 Colourless oil which slowly solidified, mp 66-67 °C, (lit. mp 75 °C); 
νmax(neat)/cm-1 3062, 3030, 2957, 2925, 2856, 1605, 1596, 1499, 1471, 1448, 1262, 1221, 741, 698, 621; 
δH(250 MHz; CDCl3) 4.39-4.41 (1 H, m), 7.10-7.47 (15 H, m); δC(62.5 MHz; CDCl3) 68.0, 68.3, 126.3, 
126.8, 127.5, 127.6, 127.7, 127.8 128.0, 128.2, 128.6, 135.4, 135.9, 141.1.  
 
1-Phenylcyclohexene oxide.12 Colourless oil; νmax(neat)/cm-1 3084, 1602, 1495, 1446, 1359, 1249, 1173, 
1132, 1079, 1030, 993, 974; δH(250 MHz; CDCl3) 1.22-1.35 (1 H, m), 1.53-1.64 (3 H m), 1.99-2.06 (2 H, m) 
2.16-2.18 (1 H, m), 2.26-2.32 (1 H, m), 3.10 (1 H, t, J 2.0 Hz), 7.28-7.44 (5 H, m); δC (62.5 MHz; CDCl3) 
19.8, 20.1, 24.7, 28.2, 60.1, 61.8, 125.3, 127.1, 128.2, 142.8.  
 
1-Phenyl-3,4-dihydronaphthalene oxide.12 Pale yellow solid; mp 104-106 °C, (lit.13 mp 94-97 °C); 
νmax(nujol)/cm-1 1602, 1486, 1307, 1155, 1074, 1042, 953; δH(250 MHz; CDCl3) 2.10 (1 H, td, J 5.8, 13.7 
Hz), 2.49-2.60 (1 H, m), 2.77 (1 H, dd, J 5.6, 15.5 Hz), 2.98-3.06 (1 H, m), 3.71 (1 H, d, J 3.1 Hz), 7.11-7.31 
(4 H, m), 7.45-7.61 (5 H, m); δC(62.5 MHz; CDCl3) 22.1, 25.4, 60.9, 63.0, 126.0, 127.7, 127.9, 128.1, 128.2, 
128.6, 129.8, 135.0, 137.5, 138.8.  
 
trans-Stilbene oxide.,14 Colourless solid; mp 66-67 °C, (lit.15 mp 61-63 °C). νmax(nujol)/cm-1 1601, 1492, 
1284, 1176, 1157, 1094, 1072, 1025; δH(400 MHz; CDCl3) 3.84 (2 H, s), 7.28-7.37 (10 H m); δC(100 MHz; 
CDCl3) 63.3, 126.0, 128.6, 129.3, 137.6.  
 
Indene oxide:16 Colourless oil; νmax(neat)/cm-1 3027, 2917, 1482, 1464, 1390, 1372, 1232, 1183, 1142, 829, 
758, 745, 723; δH(250 MHz; CDCl3) 2.97 (1 H, dd, J 2.7 and 18.1 Hz), 3.21 (1 H, d, J 17.6 Hz), 4.13 (1 H, t, 
J 3.0 Hz), 4.26 (1 H, dd, J 1.1 and 2.8 Hz), 7.14-7.29 (3 H, m), 7.49 (1 H, dd, J 1.7 and 6.6 Hz); δC(100 
MHz; CDCl3) 34.6, 57.6, 59.1, 125.2, 126.1, 126.3, 128.6, 141.0, 143.6.  
 
1,2-Dihydronapthylene oxide:17 Colourless oil; νmax(neat)/cm-1 3059, 3028, 2930, 2850, 1602, 1493, 1316, 
1129, 1088, 1030, 964; δH(400 MHz; CDCl3) 1.60-1.70 (1 H, m), 2.31-2.39 (1 H, m,), 2.45 (1 H, dd, J 15.6 
and 5.6 Hz), 2.65-2.70 (1 H, m), 3.65 (1 H, t, J 4.0 Hz), 3.78 (1 H, d, J 4.4 Hz), 7.01 (1 H, d, J 7.2 Hz), 7.14-
7.23 (2 H, m), 7.33 (1 H, d, J 7.2 Hz); δC(100 MHz; CDCl3) 22.2 24.8, 55.2, 55.5, 126.5, 128.8, 128.8, 
129.9, 132.9, 137.1. 
 
cis-β-Methylstyrene oxide:17 Colourless oil; νmax(neat)/cm-1 3061, 2994, 1604, 1496, 1450, 1258, 1149, 
9563, 853, 742, 700, 619; δH(250 MHz; CDCl3) 1.12, (3 H, d, J 5.4 Hz), 3.32-3.40 (1 H, m), 4.08 (1 H, d, J 
4.3 Hz), 7.24-7.39 (5 H, m); δC(62.5 MHz; CDCl3) 12.8, 55.4, 57.8, 126.9, 127.7, 128.3, 135.8. 
 
cis-2,3-Epoxyheptene:18 Colourless oil, 68% yield; νmax(neat)/cm-1 2959, 2930 2874, 1390, 1259, 1218, 
1151, 1114, 1032, 752; δH(400 MHz; CDCl3) 0.93 (3 H, t, J 8.0 Hz), 1.20 (3 H, d, J 4.0 Hz), 1.32-1.50 (6 H, 
m), 2.86-2.91 (1 H, m), 2.99-3.06 (1 H, m); δC(100 MHz; CDCl3) 12.2, 13.0, 21.6, 26.2, 27.6, 51.6, 56.1. 
 
6-Cyanobenzopyran oxide:19 Colourless oil which solidified: νmax(film)/cm-1 3089, 3038, 2979, 2934, 2226, 
1615, 1579, 1490, 1346, 1279, 1157, 1107, 1046, 955; δH(400 MHz; CDCl3) 1.22 (3 H, s), 1.52 (3 H, s), 
3.47 (1 H, d, J 4.4 Hz), 3.86 (1 H, d, J 4.4 Hz), 6.79 (1 H, d, J 8.4 Hz), 7.45 (1 H, dd, J 2.0, 8.4 Hz), 7.58 (1 
H, d, J 2.4 Hz); δC(100 MHz; CDCl3) 23.4, 25.9, 50.3, 62.7, 75.1, 104.7, 119.0, 119.2, 121.5, 134.2, 134.8, 
156.87. 
 
6-Nitrobenzopyran oxide:19 Colourless oil which solidified: νmax(film)/cm-13075, 2926, 2850, 1621, 1590, 
1518, 1344, 1281, 1209, 1160, 1088, 955; δH(400 MHz; CDCl3) 1.33 (3 H, s), 1.63 (3 H, s), 3.57 (1 H, dd, J 
4.4 Hz), 4.00 (1 H, d, J 4.4 Hz), 6.89 (1 H, d, J 9.0 Hz), 8.15 (1 H, dd, J 2.8, 9.0 Hz), 8.30 (1 H, d, J 2.8 Hz); 
δC(100 MHz; CDCl3) 23.1, 25.5, 50.0, 62.1, 75.2, 118.5, 120.3, 125.8, 126.3, 141.5, 158.3. 
 
6-Chlorobenzopyran oxide:19 Colourless oil: νmax(film)/cm-13080, 2985, 2933, 1611, 1579, 1478, 1366, 
1339, 1268, 1237, 1202, 1168, 1103, 1087, 1036, 954; δH(400 MHz; CDCl3) 1.17 (3 H, s), 1.50 (3 H, s), 
3.41 (1 H, dd, J 4.4 Hz), 3.77 (1 H, d, J 4.4 Hz), 6.67 (1 H, d, J 8.6 Hz), 7.11 (1 H, dd, J 2.6 and 8.6 Hz), 
7.24 (1 H, d, J 2.6 Hz); δC(100 MHz; CDCl3) 22.5, 25.6, 50.4, 62.6, 73.4, 119.4, 121.6, 125.7, 129.2, 130.2, 
151.2. 
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